▸ 1 Oct 2026, 16:36 Notification of cessation of securities - RCE Securities Administration
▸ 29 Sep 2026, 16:47 Resolutions under section 249N of the Corporations Act Meetings & Governance
▸ 18 Sep 2026, 16:10 2026 Annual General Meeting Meetings & Governance
▸ 2 Sep 2026, 13:12 Results of General Meeting Meetings & Governance
▸ 2 Sep 2026, 10:01 General Meeting Presentation Presentations
▸ 31 Aug 2026, 19:28 Appendix 4G Company Administration
▸ 31 Aug 2026, 19:16 Appendix 4E and FY26 Annual Report Financial Results
▸ 19 Aug 2026, 11:02 HREC Approves Comparator Study for Pivotal Phase 3 DFI Company Update
▸ 6 Aug 2026, 16:55 Change of Director's Interest Notices (x4) Director Interests
▸ 4 Aug 2026, 16:12 Cleansing Notice Securities Administration
▸ 3 Aug 2026, 08:23 Application for quotation of securities - RCE Securities Administration
▸ 31 Jul 2026, 11:32 Completion of Share Purchase Plan and Shortfall Notice Capital Raising
▸ 31 Jul 2026, 11:30 Application for quotation of securities - RCE Securities Administration
▸ 31 Jul 2026, 09:04 Notice of General Meeting/Proxy Form Meetings & Governance
▸ 30 Jul 2026, 10:38 U.S. Government Releases US$66.9B AMR Biodefense Strategy Company Update
▸ 21 Jul 2026, 12:50 Investor Webinar - Q4 FY26 Investor Presentation Deck Presentations
▸ 21 Jul 2026, 12:27 Investor Webinar - 2.30PM (AEST) 21 July 2026 Presentations
▸ 21 Jul 2026, 12:20 Quarterly Activities/Appendix 4C Cash Flow Report Quarterly Reports
▸ 20 Jul 2026, 09:33 Update - Proposed issue of securities - RCE Securities Administration
▸ 20 Jul 2026, 09:29 Extension to Share Purchase Plan Closing Date Capital Raising
▸ 14 Jul 2026, 08:56 Vietnamese Patent Granted for RECCE Anti-Infectives Company Update
▸ 6 Jul 2026, 09:06 Share Purchase Plan - Letter and Offer Booklet Capital Raising
▸ 3 Jul 2026, 14:31 Cleansing Notice Securities Administration
▸ 3 Jul 2026, 14:25 Application for quotation of securities - RCE Securities Administration
▸ 2 Jul 2026, 16:26 Notification of cessation of securities - RCE Securities Administration
▸ 1 Jul 2026, 11:30 Cleansing Notice Securities Administration
▸ 1 Jul 2026, 11:24 Application for quotation of securities - RCE Securities Administration
▸ 1 Jul 2026, 11:10 Application for quotation of securities - RCE Securities Administration
▸ 1 Jul 2026, 11:04 Application for quotation of securities - RCE Securities Administration
▸ 1 Jul 2026, 09:07 AUD $3.7M Income Tax Refund Received Company Update
▸ 26 Jun 2026, 18:00 Proposed issue of securities - RCE Securities Administration
▸ 26 Jun 2026, 10:35 RCE Investor Presentation Presentations
▸ 26 Jun 2026, 10:19 Proposed issue of securities - RCE Securities Administration
▸ 26 Jun 2026, 10:03 Placement & SPP to raise $8 million Capital Raising
▸ 24 Jun 2026, 10:08 Trading Halt Trading Halt / Suspension
▸ 24 Jun 2026, 09:54 Pause in Trading Trading Halt / Suspension
▸ 22 Jun 2026, 10:03 HREC Approval Accelerates Global Phase 3 DFI Strategy Company Update
▸ 27 May 2026, 13:49 Addendum to Recce Signs Middle East Licensing Term Sheet Company Update
▸ 27 May 2026, 09:48 Recce Signs Middle East Licensing Term Sheet Company Update
▸ 30 Apr 2026, 17:03 Quarterly Activities/Appendix 4C Cash Flow Report Quarterly Reports
▸ 21 Apr 2026, 10:52 Positive Regulatory Inspection Outcome for Phase 3 Trial Company Update
▸ 15 Apr 2026, 17:28 Notification of cessation of securities - RCE Securities Administration
▸ 24 Mar 2026, 11:52 Brazil Patent Granted for RECCE Anti-Infectives Company Update
▸ 19 Mar 2026, 10:43 RCE Investor Webinar Presentation Deck Presentations
▸ 17 Mar 2026, 15:00 RCE Investor Webinar Presentation Presentations
▸ 27 Feb 2026, 18:02 Appendix 4D and Interim Financial Report Financial Results
▸ 24 Feb 2026, 17:51 Change of Director's Interest Notices (x5) Director Interests
▸ 24 Feb 2026, 17:17 Notification of cessation of securities - RCE Securities Administration
▸ 2 Feb 2026, 08:58 Recce Enters Second U.S. Department of Defense R&D Agreement Company Update
▸ 30 Jan 2026, 13:01 Quarterly Activities/Appendix 4C Cash Flow Report Quarterly Reports
▸ 14 Jan 2026, 10:37 AUD $5.3m R&D Rebate Received Periodic Reports
▸ 16 Dec 2025, 09:48 RCE Awarded Advanced Overseas Finding up to A$85m Periodic Reports
▸ 27 Nov 2025, 10:05 Hong Kong Patent Granted for RECCE Anti-Infectives Company Update
▸ 26 Nov 2025, 09:50 Positive Efficacy Data for Inhaled R327 in HAP/VAP Model Company Update
▸ 14 Nov 2025, 16:08 Passing of Dr Graham Melrose - Recce founder and inventor Company Administration
▸ 5 Nov 2025, 14:09 Results of Meeting Meetings & Governance
▸ 5 Nov 2025, 08:58 AGM Presentation Presentations
▸ 31 Oct 2025, 17:21 Quarterly Activities/Appendix 4C Cash Flow Report Quarterly Reports
▸ 14 Oct 2025, 18:21 Change of Director's Interest Notices Director Interests
▸ 8 Oct 2025, 08:34 Notification of cessation of securities - RCE Securities Administration
▸ 8 Oct 2025, 08:33 Update - Notification of buy-back - RCE Buybacks & Capital Management
▸ 7 Oct 2025, 16:41 Update - Notification of buy-back - RCE Other
▸ 3 Oct 2025, 11:54 Notice of Annual General Meeting/Proxy Form Presentations
▸ 25 Sep 2025, 09:49 Patient Dosing Underway in Ph 3 Indonesia DFI Trial Company Update
▸ 15 Sep 2025, 16:46 2025 Annual General Meeting Meetings & Governance
▸ 29 Aug 2025, 19:29 Appendix 4G Company Administration
▸ 29 Aug 2025, 19:29 Annual Report to Shareholders Financial Results
▸ 29 Aug 2025, 19:27 Preliminary Final Report Financial Results
▸ 25 Aug 2025, 19:24 Notification regarding unquoted securities - RCE Securities Administration
▸ 12 Aug 2025, 10:53 R327G Highly Effective in Burn Wounds Model Company Update